This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the role of AGEs and RAGE in liver fibrosis and inflammation.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the rate of prevalence, pathophysiological mechanisms, diagnosis and risk stratification, and therapeutic options of NAFLD in women with PCOS.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the use of senolytic therapies for liver disease and inflammation.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the role of sirtuins in liver disease and inflammation.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the current knowledge on the origins and composition of KCs, their functions in maintaining hepatic homeostasis, and their involvement in both promoting and resolving liver inflammation, injury, and fibrosis.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing how cells can be isolated from the liver of untreated animals and used to analyze the effects of mediators thought to be involved in the inflammatory process.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing reliable methods to quantitatively analyze the UPR and hepatic inflammation in the mouse model of NAFLD.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the role of the gastrointestinal and liver microcirculation in inflammation and immunity.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the liver's response to injury including inflammation and fibrosis responses.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the role of inflammation in drug-induced liver injury.